Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Algernon Pharmaceuticals Inc C.AGN

Alternate Symbol(s):  AGNPF

Algernon Pharmaceuticals Inc. is a clinical-stage drug development company. The Company is focused on developing repurposed therapeutic drugs in the areas of non-alcoholic steatohepatitis (NASH), a type of liver disease, chronic kidney disease (CKD), inflammatory bowel disease (IBD), idiopathic pulmonary fibrosis (IPF) and chronic cough as well as advancing a stroke program using N, N-Dimethyltryptamine (DMT). The Company operates through two segments, which includes the development of repurposed therapeutic drugs in Canada and the facilitation of the Company’s lead drug candidates into off-label phase II clinical trials (humans) in Australia. The Company's pipeline includes NP-251 (Repirinast) and AP-188 (DMT). The Company, through its subsidiary, Algernon NeuroScience Inc., is developing AP-188 (DMT) as a potential treatment for stroke and traumatic brain injury (TBI) recovery. Its NP-251 is being developed as a potential treatment for kidney inflammation and fibrosis.


CSE:AGN - Post by User

Comment by BehStreet on Jun 05, 2020 8:21am
87 Views
Post# 31115296

RE:It's All Good Beh

RE:It's All Good BehThanks Danny. I don't post on here much anymore for that very reason. The impatience, pessimism, and ignorance is immoderate. Blaming management for the daily tick a stock price isn't worth my reply. We are up over 450% on the year and the company is delivering at lightning speed for a bio-tech. I've done my DD, I can wait months.

DannyDanboy wrote: I agree with you Beh. At this point I'm done sharing my opinions here and other places with others. Does not matter what Algernon does behind the scenes or how transparent they are with investors people here will always find a way to put a negative spin on it. Algernon releases FDA clearance and now ppl are upset about the hault. LMAO. No pleasing ppl these days I tell you. If you're long you know what a milestone this is. I could care less what we close at today.


<< Previous
Bullboard Posts
Next >>